CTLA4 and cancer: While cytotoxic T lymphocytes (CTLs) have the potential to eliminate cancer cells, their function is often suppressed due to the upregulation of immune checkpoint molecules, such as PD-1 and CTLA-4, a barrier that immunotherapies aim to overcome.